Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Hypokalemia: low levels of potassium in the blood can reduce the effectiveness of methycobal injection
This product is strictly intended for laboratory and scientific research purposes only.
That did not move them to Category 1
mechanism unexplained Relative contributions of direct peptide effects versus downstream IGF-1 actions inadequately characterized Long-term receptor sensitivity and potential for desensitization inadequately studied Individual patient variability in response not well-characterized Potential for differential effects based on endogenous growth hormone status unclear Long-Term Safety Considerations Critical safety questions remain unanswered regarding chronic peptide administration: Cardiovascular safety concerns FDA warnings cite risks of increased heart rate, systemic vasodilation, flushing, and transient hypotension Immunogenicity risks FDA identifies both peptides as potentially immunogenic with risk of serious immune reactions including anaphylaxis Cancer risk theoretical concern that chronic growth hormone/IGF-1 elevation could promote cellular proliferation
MIC injections commonly contain lipotropic compounds such as methionine, inositol, and choline, which support the bodys natural fat metabolism and metabolic processes
While this may support Muscle growth or Muscle recovery, overstimulation can lead to side effects such as joint discomfort, swelling, headaches, or fatigue
US$ 29.65
US$ 22.33
US$ 28.20
US$ 25.35
US$ 29.14
